Signup/Login

Amycretin Weight Loss Pill: Uses, Benefits, Side Effects & More

  1. Home
  2. Amycretin Weight Loss Pill: Uses, Benefits, Side Effects & More

Amycretin Weight Loss Pill: Uses, Benefits, Side Effects & More

11 / Feb

Obesity is a growing global health concern, with millions of people seeking effective solutions to manage their weight. Recently, a new medication called Amycretin has gained attention for its potential in treating obesity. Developed by Novo Nordisk, a leading pharmaceutical company known for its innovations in diabetes and obesity management, Amycretin has shown promising results in early clinical trials.

This article will explore the uses, benefits, side effects, and current research surrounding Amycretin.

What is the Amycretin Weight Loss Pill?

Amycretin is an unimolecular long-acting drug designed to aid weight loss for individuals who are overweight or obese. It functions as a dual agonist, targeting both glucagon-like peptide-1 (GLP-1) and amylin receptors. 

GLP-1 is a hormone that enhances insulin secretion and promotes a sense of fullness, while amylin helps regulate appetite and slows gastric emptying. By activating these pathways, Amycretin reduces appetite and supports weight loss effectively.

How Does Amycretin Pill Work?

Amycretin’s mechanism of action involves stimulating two critical pathways:

  1. GLP-1 Receptor Activation: GLP-1 receptors are responsible for increasing insulin secretion, reducing glucagon release, and slowing gastric emptying. These actions contribute to reduced food intake and better glucose control.
  2. Amylin Receptor Activation: Amylin works synergistically with insulin to regulate blood glucose levels. It also slows gastric emptying and promotes satiety, helping to reduce overall caloric intake.

By targeting both receptors, Amycretin offers a comprehensive approach to weight management, potentially leading to more significant weight loss than medications that target a single pathway.

Clinical Trials and Efficacy of Amycretin Weight Loss Pill

Novo Nordisk conducted a phase 1b/2a clinical trial to evaluate the safety, tolerability, and efficacy of Amycretin. The trial included 125 participants who were overweight or obese, receiving Amycretin via subcutaneous injection once weekly over varying durations.

Weight Loss Outcomes:

  1. 1.25 mg dose (20 weeks): 9.7% weight loss
  2. 5 mg dose (28 weeks): 16.2% weight loss
  3. 20 mg dose (36 weeks): 22.0% weight loss

In contrast, placebo-treated participants showed minor weight gains of 1.9%, 2.3%, and 2.0% over the same periods.

Safety Profile: The safety profile of Amycretin was consistent with incretin-based therapies, with gastrointestinal issues such as nausea and vomiting being the most common side effects. Most adverse events were mild to moderate.

Benefits of Amycretin Weight Loss Pill

  1. Significant Weight Reduction: Amycretin has demonstrated substantial weight loss in clinical trials, making it a promising option for individuals struggling with obesity.
  2. Dual Mechanism: By targeting both GLP-1 and amylin receptors, Amycretin provides a more comprehensive approach to weight management.
  3. Potential for Oral Administration: While current studies have focused on subcutaneous injections, an oral formulation is under development, which could enhance patient adherence.
  4. Improved Metabolic Health: Beyond weight loss, Amycretin may also improve insulin sensitivity and glycaemic control, offering additional benefits for individuals with type 2 diabetes.

Side Effects and Safety Considerations

Like any medication, Amycretin comes with potential side effects. Common adverse effects include:

– Gastrointestinal issues (nausea, vomiting, diarrhoea)

– Decreased appetite

– Fatigue

Rare but serious side effects may include:

– Hypoglycaemia (especially in individuals with diabetes)

– Pancreatitis

– Severe allergic reactions

Patients should discuss the risks and benefits of Amycretin with their healthcare provider to determine if it is suitable for their needs.

Amycretin vs Other Weight Loss Medications

Amycretin’s dual-action mechanism distinguishes it from existing weight loss drugs like Semaglutide (Wegovy) and Tirzepatide (Mounjaro).

Amycretin vs. Wegovy (Semaglutide)

Mechanism of Action: Wegovy (semaglutide) only targets the GLP-1 receptor, whereas Amycretin targets both GLP-1 and amylin receptors, potentially enhancing weight loss outcomes.

Efficacy: Clinical trials for Wegovy report weight loss of around 15% on average, whereas Amycretin has demonstrated up to 22% weight loss in trials.

Side Effects: Both drugs share common gastrointestinal side effects, but amycretin’s amylin receptor activation may further enhance satiety and glucose control.

Administration: Both are currently available as subcutaneous injections, but an oral form of Amycretin is under development.

Amycretin vs. Mounjaro (Tirzepatide)

Mechanism of Action: Mounjaro (Tirzepatide) is a dual GIP and GLP-1 receptor agonist, while Amycretin combines GLP-1 and amylin receptor activation.

Efficacy: Mounjaro has shown weight loss of around 20% in clinical trials, slightly lower than amycretin’s reported 22%.

Side Effects: Both drugs have similar gastrointestinal side effects, but Mounjaro’s GIP activation may provide additional metabolic benefits beyond weight loss.

Administration: Mounjaro is administered via injection, and amycretin’s oral formulation is in development, potentially offering greater convenience.

Overall, amycretin’s unique combination of GLP-1 and amylin receptor activation may offer superior weight loss benefits compared to Wegovy and Mounjaro. However, long-term studies are needed to establish its full safety profile and efficacy in broader patient populations.

Future Directions

Encouraged by initial findings, Novo Nordisk plans to continue the development of Amycretin. Future studies will focus on long-term efficacy, safety, and the feasibility of oral administration.

Takeaways

Amycretin represents a novel and promising approach to obesity management. With its dual receptor activation, it has the potential to deliver significant weight loss and metabolic benefits. As research progresses, Amycretin could become a valuable tool in combating obesity, offering hope to millions struggling with weight management.

At The Care Pharmacy, we are committed to providing the latest information on innovative treatments like Amycretin to help you make informed decisions about your health. For personalised advice and support, contact our expert pharmacists today.

FAQs

  1. What is Amycretin used for?

Amycretin is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily used to manage weight and type 2 diabetes by improving blood sugar control and enhancing insulin secretion.

  1. Is Amycretin available in the UK?

As of now, Amycretin is not available in the UK. It is an investigational drug currently undergoing clinical trials for weight loss and is not yet approved for public use. Novo Nordisk, the developer of Amycretin, anticipates that the drug could be available to consumers after 2026. 

  1. What is the new obesity pill for Novo Nordisk?

Novo Nordisk is developing a new oral obesity medication called Amycretin. Amycretin is a single molecule that operates as a GLP-1 receptor agonist and amylin receptor agonist. It is under development by Novo Nordisk as a weight loss drug; unlike some competitors, it can be delivered orally. 

In a Phase I clinical trial, participants taking Amycretin lost up to 13% of their body weight over 12 weeks. Based on these results, Novo Nordisk is planning further clinical development of Amycretin in adults with overweight or obesity.

Additionally, Novo Nordisk is developing CagriSema, a combination of Cagrilintide and Semaglutide, as a once-weekly injectable treatment for adults with overweight or obesity.

  1. What are the side effects of Amycretin?

In early clinical trials, Amycretin has been associated with mild to moderate gastrointestinal side effects, primarily nausea and vomiting. These adverse effects are consistent with those observed in other GLP-1 receptor agonist treatments.  As research progresses, more comprehensive data on amycretin’s safety profile will become available.

Written by:
  • Uzma Aslam
Medically reviewed by:
  • Mohammed Ismail Lakhi
Verified by:
  • Muhammed Luqman Asghar

Recent Posts

C0VID-19 Vaccine

The C0VID-19 vaccine works by training the immune system to recognise and fight the virus that causes C0VID-19, specifically its spike protein. C0VID-19 is a respiratory tract disease, mainly spread through respiratory droplets, aerosols, and direct contact with other people.

Price Per Dose: £ 59.99

Chickenpox Vaccine

Chickenpox is a common viral infection caused by the varicella zoster virus. This vaccine is suitable for adults and children aged between one and 65 years.

Price Per Dose: £ 74.99

Shingles Vaccine

Shingles vaccine helps to protect against getting shingles.Shingles is an infection that causes a painful rash and It’s suitable for adults aged 50 and above.

Price Per Dose: £ 219.99

Yellow Fever

Yellow fever is a viral disease caused by the yellow fever virus and transmitted through the bite of infected mosquitoes. It can lead to severe symptoms, including fever, headache, jaundice, and in severe cases, organ failure and death. Travelers visiting areas where yellow fever is endemic, particularly in tropical regions of Africa and South America, are at risk of contracting the disease. The yellow fever vaccine is a highly effective preventive measure for travelers. The typical dosing routine involves a single dose of the vaccine, which provides immunity for at least 10 years. Some countries require proof of yellow fever vaccination for entry. It is essential for travelers to get vaccinated before their journey to protect themselves and prevent the spread of the disease.

Price Per Dose: £ 69.99

Typhoid

Typhoid is a bacterial infection caused by the bacterium Salmonella Typhi. It spreads through contaminated food and water, and its symptoms include high fever, abdominal pain, and severe gastrointestinal issues. Travelers visiting regions with poor sanitation and inadequate hygiene standards are at a heightened risk of contracting typhoid. The typhoid vaccine is a crucial preventive measure for travelers. There are two types of typhoid vaccines available – the injectable vaccine and the oral vaccine. The typical dosing routine for the injectable vaccine involves a single shot. Get vaccinated against typhoid – it is essential for travelers to avoid the risk of infection and enjoy a safe and healthy journey.

Price Per Dose: £ 39.99

TBE (Tick-Borne Encephalitis)

Tick-borne encephalitis (TBE) is a viral disease transmitted to humans through the bite of infected ticks. It primarily affects the central nervous system and can lead to severe neurological symptoms, such as inflammation of the brain. Travelers visiting regions where TBE is endemic, especially during outdoor activities in wooded or grassy areas, face an increased risk of contracting the disease. The TBE vaccine provides effective protection against this potentially serious infection. The typical dosing routine involves a series of two to three doses, depending on the vaccine type used. Booster doses are also recommended to maintain immunity over time. Getting vaccinated against TBE is essential for travelers to mitigate the risk of infection and enjoy a safe and enjoyable trip.

Price Per Dose: £ 64.99

Rabies

Rabies is a deadly viral disease that affects the nervous system and is primarily transmitted through the bite of infected animals. The virus can cause a fatal infection if not treated promptly. Travelers, especially those visiting regions where rabies is prevalent and may have encounters with stray animals or wildlife, face an increased risk of contracting the disease. The Rabies vaccine is a preventive measure to protect against rabies. The typical dosing routine involves a series of doses. Typically this is given before potential exposure to the virus or after a potential exposure to ensure effective protection. Getting vaccinated against rabies is crucial for travelers to avoid the devastating consequences of this lethal infection and enjoy a safe journey.

Price Per Dose: £ 69.99

Pneumococcal (PCV/ PPSV)

The Pneumococcal vaccine, available as pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine (PPSV), provides protection against various strains of pneumococcal bacteria. These bacteria can cause serious infections, including pneumonia, meningitis, and bloodstream infections. The PCV is primarily given to infants and young children, while PPSV is typically administered to older adults and individuals with specific medical conditions.

The typical dosing routine for PCV involves a series of doses given at specific ages during infancy. PPSV requires a single dose for most individuals, with a possible booster dose after a certain period.

Price Per Dose (PCV): £ 89.99

Price Per Dose (PPSV): £ 49.99

MMR

The MMR vaccine is a combination vaccine that provides protection against three highly contagious diseases: measles, mumps, and rubella. It is a crucial part of routine childhood immunizations. Also, it is recommended for adults who have not been vaccinated or lack immunity to these diseases. The typical dosing routine for the MMR vaccine involves two doses. The first dose is administered around the age of 12 to 15 months, and the second dose given between 4 to 6 years old. Getting vaccinated with the MMR vaccine is essential to prevent the spread of these potentially serious infections.

Ensure you and your loved ones are protected against measles, mumps, and rubella! Our experienced healthcare professionals are ready to provide you with the MMR vaccine. Come and get vaccinated with us to safeguard your health and contribute to a healthier community.

Price Per Dose: £ 44.99

Meningitis B

Meningitis B is a bacterial infection causing inflammation of the brain and spinal cord membranes. The risk of contracting it while traveling is generally low but increases in crowded settings. Be aware of the symptoms and ensure protection by getting vaccinated with us before your journey. Stay informed and stay safe during your travels.

Price Per Dose: £ 109.99

Meningitis ACWY

Meningitis ACWY is a bacterial infection that causes inflammation of the membranes surrounding the brain and spinal cord. The disease is caused by different types of bacteria, namely A, C, W, and Y. It can lead to severe health complications, including brain damage and death. Travelers, especially those visiting crowded settings like festivals, pilgrimages, or dormitory-style accommodations, may face an increased risk of contracting meningitis ACWY. To minimize the risk, vaccination is recommended, particularly when traveling to areas with active outbreaks or regions where the disease is more prevalent.

Price Per Dose: £ 49.99

Japanese Encephalitis

Japanese encephalitis is a viral infection transmitted through mosquito bites, primarily found in rural areas of Asia and the Western Pacific. The disease affects the brain and can lead to severe inflammation, resulting in neurological complications or even death. Travelers visiting or residing in regions where Japanese encephalitis is endemic, especially during the peak mosquito season, face an increased risk of contracting the virus. Taking preventive measures, such as using mosquito repellents, wearing protective clothing, and getting vaccinated, is crucial for travelers to reduce their risk of Japanese encephalitis and enjoy a safe journey.

The typical dosing for the Japanese encephalitis vaccine involves a two-dose series, with the second dose administered 28 days after the first.

Price Per Course: £ 199.99

HPV

Human papillomavirus (HPV) is a common viral infection that is primarily transmitted through sexual contact. There are multiple strains of HPV, some of which can lead to genital warts and others that can cause various cancers, including cervical, anal, and throat cancer. Travelers, especially those engaging in risky sexual behaviors, may be at risk of contracting HPV, as the virus can be prevalent worldwide. Practicing safe sex and getting vaccinated against HPV are essential preventive measures for travelers to reduce their risk of infection and the associated health complications.

Price Per Dose: £ 164.99

Hepatitis A Typhoid Combined

The Hepatitis A Typhoid combined vaccine is a convenient option for travelers seeking protection against both Hepatitis A and typhoid fever. The typical dosing schedule involves a single shot, providing immunity against both infections. This combination vaccine saves time and effort while ensuring comprehensive coverage against these travel-related diseases.

Price Per Course: £ 89.99

Hepatitis A Hepatitis B Combined

The Hepatitis A Hepatitis B combined vaccine offers protection against both Hepatitis A and Hepatitis B viruses. The typical dosing schedule involves three doses, administered at 0, 1, and 6 months. This vaccine is an excellent option for individuals seeking comprehensive protection against both hepatitis viruses in a convenient single shot.

Price Per Course: £249.99

Cholera

Cholera is a severe bacterial infection causing profuse watery diarrhea and vomiting, primarily transmitted through contaminated food and water. Traveling abroad increases the risk of contracting cholera. This is especially true in areas with poor sanitation or during outbreaks. Taking preventive measures such as getting vaccinated is crucial for travelers’ protection.

The Cholera vaccine is typically administered as two-doses, the first dose given at least one week before potential exposure to cholera and the second dose taken at least one week after the first dose.

Traveling to high-risk areas? Our trained healthcare professionals are here to help! Come and get your cholera vaccine today to ensure a safe and worry-free journey.

Price Per Course: £59.99

Hepatitis B

Hepatitis B is a viral liver infection primarily transmitted through infected blood or body fluids. Travelers and others in high-risk situations, such as unsafe medical procedures or unprotected sex, face an increased risk of contracting the virus. Vaccination against hepatitis B and adopting preventive measures are essential to safeguard against this serious infection.

The typical dosing for the hepatitis B vaccine involves a series of three doses. The initial dose is followed by a second dose at least one month later, and a third dose six months after the first dose. This vaccination provides long-term protection against hepatitis B.

Price Per Course: £149.99

Hepatitis A

Hepatitis A is a viral infection that primarily affects the liver, causing inflammation and potentially leading to symptoms like fever, nausea, and jaundice (yellowing of the skin and eyes). The virus is commonly transmitted through consuming contaminated food or water. While hepatitis A can occur anywhere, the risk of contracting it increases significantly when traveling abroad, especially to regions with poor sanitation and hygiene practices. Tourists may unknowingly consume contaminated food or water, putting them at risk of infection. It is crucial for travelers to be aware of the risk and take preventive measures, such as getting vaccinated against hepatitis A, to protect themselves during their journeys.

The typical dosing for the hepatitis A vaccine involves a two-dose series. The first dose is administered before potential exposure to the virus, and the second dose is given 6 to 18 months later to provide long-term immunity. For a booster dose, a single shot is usually recommended for ongoing protection after the initial series. Ensuring full vaccination with the recommended dosing schedule is essential to prevent hepatitis A infection and maintain immunity, especially when traveling to regions with a higher risk of the disease.

Price Per Dose: £59.99

Diptheria, Tetanus And Polio

Diphtheria, tetanus, and polio are significant infectious diseases to consider when traveling abroad. Diphtheria is a respiratory infection that causes breathing difficulties and potentially life-threatening complications. Tetanus, also known as “lockjaw,” induces severe muscle stiffness and spasms, transmitted through contaminated wounds. Polio is a viral infection that can lead to paralysis, impacting the nervous system. While vaccinations have controlled these diseases in many places, some regions may still pose risks.

Before traveling, it is recommended to get a single booster dose for diphtheria, tetanus, and polio. This reinforces immunity and reduces the risk of contracting these diseases in regions where they may still be prevalent. Ensure a safe and healthy journey by receiving the recommended booster before you travel.

Price Per Course: £39.99